David A. Andry OTR/L, SVP Sales & Business Development


David graduated from Florida International University in 1993 with his Bachelor's Degree in Occupational Therapy. He has spent 27 years working as an occupational therapist in various areas including inpatient and outpatient rehab, long term care, acute care settings, home health and wound care. In addition, throughout his career as an occupational therapist, he has always worked in pediatrics as well and has specialized in this area. He continues to devote his time to working with children on weekends. David has also worked in extensively in the pharmaceutical arena from sourcing products, product development, and unit dose solutions for hospitals via in-house repackaging and sales. David brings his vast clinical knowledge and sales edge to provide quality, customer oriented service; not only to his customers, but also the patients, pharmacies, and physicians they serve.

Companies Worked For: Parkway Regional Medical Center, Mercy Hospital, Hearing and Speech Center of Florida, Theracare Home Health, Quali-Care Home Health, Florida Homebound, Handwriting Without Tears, Cabin John, MD, Abilities in Motion-Owner/Operator serving schools in migrant farmworkers communities and homebound children, AHP Group, Gensco Pharma.

Carlos Alfaras, Chairman & CEO, Board Member


Carlos Alfaras is a Proven Leader in Pharma, Biotech and Healthcare as a C-Suite Executive with a demonstrated history of success and Skilled Leadership in Pharmaceutical, Biotechnology, Medical Device, Strategic Planning and Business Development.

Expertise includes: Commercialization, Global Branding Strategy & Marketing, Business & Sales Development, Mergers & Acquisitions, Proven Commercial Growth Strategies in the Healthcare, Biotechnology and generic/Brand Pharmaceutical markets, Healthcare Distribution, Drug Delivery and Product Inventions, Executive Administration, Personnel Growth and Team Building. Mr. Alfaras holds patents on Transdermal Drug Delivery and unique Metered Dose Technology. He attended the University of Miami, majoring in Biology/Pre-Medical studies with a minor in Genetics and utilized this education and experience to enter the pharmaceutical management world. In his dedication for the pursuit of excellence, he has had successes in creating growth in revenues and technology footprints at every company he has been associated with through education, team building, strategic planning and efficiently determining the development strategies for all. He has held the following positions: Purchasing Director, National Drug Wholesale (Acquired by Harvey Labs); Director of Purchasing and GM, PHARMED Group; Vice President, Sunshine Medical C.O.O, DNA Pharmaceuticals; Head of Business Development, Bioniche Pharma (Acquired by Mylan Specialty); Senior Director Alternate Care and Business Development, ANDA Pharmaceuticals/ANDRX Corporation(Acquired by WATSON Pharmaceuticals); Executive Director, Head of Business Strategy and Global Development ANDA/Watson Pharmaceuticals (Acquired by TEVA); President & CEO, AHP Group; President & CEO, Gensco Pharma. Board Member of Versea Holdings, ImmuneBioScience and NEO7Bioscience. He is also a member of the following non-profit organizations: Catholic Charities, I9 Sports, and Special Olympics International. Carlos Alfaras is dedicated to building a legacy of mentorship both professionally and personally and has been recognized as such by developing an ever-growing list of successful persons in the industry.